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Abstract
Studies of skeletal muscle disuse, either in patients on bed rest or experimentally in animals 
(immobilization), have demonstrated that decreased protein synthesis is common, with transient 
parallel increases in protein degradation. Muscle disuse atrophy involves a process of transition 
from slow to fast myosin fiber types. A shift toward glycolysis, decreased capacity for fat 
oxidation, and substrate accumulation in atrophied muscles have been reported, as has 
accommodation of the liver with an increased gluconeogenic capacity. Recent studies have 
modeled skeletal muscle disuse by using cyclic stretch of differentiated myotubes (C2C12), which 
mimics the loading pattern of mature skeletal muscle, followed by cessation of stretch. We utilized 
this model to determine the metabolic changes using non-targeted metabolomics analysis of the 
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media. We identified increases in amino acids resulting from protein degradation (largely 
sarcomere) that occurs with muscle atrophy that are involved in feeding the Kreb’s cycle through 
anaplerosis. Specifically, we identified increased alanine/proline metabolism (significantly 
elevated proline, alanine, glutamine, and asparagine) and increased α-ketoglutaric acid, the 
proposed Kreb’s cycle intermediate being fed by the alanine/proline metabolic anaplerotic 
mechanism. Additionally, several unique pathways not clearly delineated in previous studies of 
muscle unloading were seen, including: 1) elevated keto-acids derived from branched chain amino 
aicds (i.e. 2-ketoleucine and 2-keovaline), which feed into a metabolic pathway supplying acetyl-
CoA and 2-hydroxybutyrate (also significantly increased); and 2) elevated guanine, an 
intermediate of purine metabolism, was seen at 12 hours unloading. Given the interest in targeting 
different aspects of the ubiquitin proteasome system to inhibit protein degradation, this C2C12 
system may allow the identification of direct and indirect alterations in metabolism due to 
anaplerosis or through other yet to be identified mechanisms using a non-targeted metabolomics 
approach.
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1. Introduction
Recovery from injury and illness can cause extended periods of muscle disuse and/or 
unloading resulting in rapid skeletal muscle atrophy and loss of functional strength1–3. The 
extent of muscle loss that occurs during illness is an important predictor of hospitalization 
duration and need for rehabilitation4. The resulting decline in functional capacity and 
strength, decline in basal metabolic rate, and onset of insulin resistance reported to be some 
of the sequelae in humans5. Since the signs of muscle disuse atrophy occurs rapidly, 
understanding the short term alterations that occur may help us better appreciate their 
contribution to sarcopenia and elucidate ways in which to counteract the particularly fast and 
severe consequences that result.
Studies of skeletal muscle disuse either in patients on bed rest or experimentally in animals 
(immobilization) have demonstrated that decreased protein synthesis is common, with 
transient parallel increases in protein degradation (as recently reviewed5). Muscle disuse 
atrophy involves a process of transition from slow to fast myosin fiber types6. A shift toward 
glycolysis, decreased capacity for fat oxidation, and substrate accumulation in atrophied 
muscles have been reported, as has accommodation of the liver with an increased 
gluconeogenic capacity6. These alterations in glycolysis appear to regulate more than 
carbohydrate metabolism7.
Recent studies have modeled skeletal muscle disuse by using cyclic stretch of differentiated 
myotubes (C2C12), which mimics the loading pattern of mature skeletal muscle, followed 
by cessation of stretch8. The resulting atrophy mimicked disuse atrophy and allowed 
investigation of the underlying mechanisms. In the current study, we sought to more broadly 
identify the metabolic changes that occur acutely in differentiated muscle cells using a non-
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targeted metabolomics approach of both cells and media in vitro. While we identified 
previously reported effects on glucose utilization, a host of previously undescribed 
alterations in protein metabolism was found and offers insight into the mechanisms 
underlying acute skeletal muscle disuse atrophy that may be targeted therapeutically in the 
future.
2.0 Materials and Methods
2.1 C2C12 plating and differentiation on FlexCell plates
The C2C12 mouse myoblast cell line (ATCC, CRL-1772) was plated at 30–50% confluence 
onto six-well BioFlex® culture plates (BF-3001, Flexcell International Corporation, 
Hillsborough, NC) coated with Collagen type I. Myoblasts were grown to 80% confluence 
in DMEM (4500 mg/L glucose) with 20% FBS, then differentiated to myotubes by changing 
media to DMEM with 2% horse serum supplemented with insulin (1 microM final), as 
previously described9–11. Cells were plated were then allowed to quiesce in DMEM (25 mM 
glucose) without media for 24 hours before stretch stimulus was applied to quiesce the cells, 
as previously described in the context of cardiomyocyte-induced hypertrophy by IGF-1 and 
thyroid hormone in vitro12,13.
2.2 Biomechanical stretch of differentiated C2C12 cells
Differentiated C2C12 cells were either stretched at 15% biaxial stretch for 6 hours using the 
Flexcell® FX-5000™ Compression System (Flexcell International Corporation, 
Hillsborough, NC), or used as controls (non-stretched) and incubated in parallel to 
experimental cells without stretch (non-stretched cells). The stretched differentiated C2C12 
cells were then unloaded by stopping the stretch and allowing the cells to incubate for 
another 12 hours. Media was collected at baseline, or after 6 hours of stretch, and 1, 3, 6, 
and 12 hours after the cessation of stretch. Replicate control samples and cells undergoing 
cessation of stretch were maintained under static conditions with no applied cyclic strain. In 
parallel, second experimental group of differentiated C2C12 cells were stimulated with 10% 
FBS for 6 hours to induce hypertrophy (experimental controls were incubated in parallel 
without FBS).
2.3 Imaging and cell surface area determinations
Cultured myotubes were viewed and imaged using a Zeiss inverted microscope (Axiovert 
200, Oberkochen, Germany). Three digital images per culture were captured. The images 
were analyzed for myotube length, diameter and area using ImageJ imaging software (NIH) 
as previously described8.
2.4 Non-targeted metabolomics analysis
Collection of samples (spent media) from all 6 wells was performed, and samples were 
placed on dry ice/stored at −80°C. Samples were then analyzed by GC/MS, as previously 
described14. The raw, transformed, and sorted data used for each of the three comparisons in 
the metabolomics analyses can be found in Supplemental Table 1. Up to 1 missing value per 
group was imputed using lowest value in the same group, with groups missing 2 or more 
excluded from the analysis. All data used in this analysis has been archived in the UCSD 
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Metabolomics Workbench (http://www.metabolomicsworkbench.org/), accession #(Pending 
Assignment).
2.5 Metabolomic statistical analyses
Metaboanalyst (v3.0) run on the statistical package R (v2.14.0) used metabolite peaks areas 
(as representative of concentration)19,20. Data were first normalized to a pooled average 
sample from their control and scaled using Pareto scaling feature, and then analyzed to 
calculate fold change using Metaboanalyst fold change feature. Unsupervised principal 
component analysis (PCA) was performed next, which identified the effect of stretch 
cessation as the principal source of variance. The metabolites that best differentiated the 
groups were then individually tested using univariate analysis of individual component by t-
test (Metaboanalyst v 3.0), and then the t-test and VIP significant metabolites were matched 
to metabolomics pathways using the Pathway Analysis and enrichment analysis features in 
Metaboanalyst 3.0. In addition, a Pairwise One-Way Analysis of Variance (ANOVA) and 
Fisher LSD post-hoc were conducted among all groups at different time points using 
Metaboanalyst v3.0 to delineate the changes induced by stretch and cessation. Only 
metabolites identified and detected in all groups were included in the One-Way ANOVA. If 
two or more values of each metabolite were missing in a given group, the entire metabolite 
was removed from the analysis. Data used in this study are available in Supplemental Table 
1. Heat maps were generated using the GENE-E software (http://www.broadinstitute.org/
cancer/software/GENE-E/index.html). All data is shown as mean +/− standard error of the 
mean (SEM), unless otherwise indicated.
3.0 Results
Using differentiated C2C12 myotubes seeded at the same time with equal numbers of cells, 
we cyclically stretched cells (15% at 60 cycles/min) for 6 hours, then stopped the stretch and 
collected media at 1, 3, 6, and 12 hours post-stretch. Media from the same cells were 
collected just before and 6 hours post-stretch (indicated by 0 h) was analyzed using non-
targeted metabolomics (Figure 1A). Compared to non-stretch controls, C2C12 cells 
significantly increased in cross-sectional are after 6 hours (Figure 1B). Stretch cessation 
resulted in a significant reduction in myocyte area within 3 hours (Figure 1B), which 
continued to decrease at 6 and 12 hours, respectively. To discover the alterations that 
occurred metabolically in these myocytes, we analyzed the media in the stretch cells and 
compared it to non-stretched cells in vitro, investigating each of the five times analyzed (6 
hours stretch, and 1, 3, 6, and 12 hours post-stretch cessation).
Using non-targeted metabolomics analysis, we compared the metabolites found in control 
no-stretch cell media to cells stretched for 6 hours without serum (Figure 2). We identified 
eighty-two metabolites (of 110 substances peaks recorded)(Figure 2A). Of the 82 
metabolites named, 12 were significantly different from non-stretch controls by t-test 
(Figure 2B). By category, stretch affected arginine/proline metabolism and starch/sucrose 
metabolism (Figure 2C). We identified 84 metabolites in serum-stimulated C2C12 cells 
(Supplemental Figure 1A), with 32 of them significantly different from parallel controls 
(Supplemental Figure 1B). Like stretch-induced hypertrophy, serum-stimulated C2C12 cells 
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showed significant alterations in protein biosynthesis and alanine metabolic pathway as the 
most enriched pathways and lowest p-value (Supplemental Figure 1). Twelve (12) 
significantly altered metabolites were found in the stretch challenged C2C12 cells compared 
to thirty-two (32) in the serum-induced after 6 hours illustrate the many differences in these 
stimuli as well, including citrate cycle, arginine/proline metabolism, and glycine/serine/
threonine metabolic pathways identified (Supplemental Figure 1). Pathway enrichment 
analysis of the 6 hours stretch and 6-hour serum significant metabolites illustrate the 
similarities between the two, including “protein biosynthesis” and “alanine metabolism” 
having the lowest p values, while citric acid cycle changes were unique to the serum-
stimulated pathway (Supplemental Figure 2).
After identifying the metabolic alterations that occurred with stretch, we next determined the 
metabolic changes at 1, 3, 6, and 12 hours after (Figures 3–6). After 1 hour, three 
metabolites were significantly different between groups (of 83 metabolites identified from 
191 substance peaks recorded)(Figure 3A and 3B), involving starch and sucrose metabolism 
(Figure 3C). Similarly, after 3 hours of stretch cessation, nine metabolites were significantly 
different between groups (from 87 metabolites identified from 197 substances peaks 
recorded)(Figure 4A and 4B), also involving aminoacyl-tRNA biosynthesis (Figure 4C). At 
6 hours of stretch cessation, 16 metabolites were significantly different between groups (of 
86 metabolites identified from 196 substances peaks recorded)(Figure 5A and 5B), involving 
valine/leucine/isoleucine biosynthesis, pyruvate metabolism, and aminoacyl-tRNA 
biosynthesis (Figure 5C). By 12 hours of stretch cessation, 30 metabolites were significantly 
different (of 80 metabolites identified from 193 substances peaks recorded)(Figure 6A and 
6B), involving primarily intermediate metabolism (alanine/aspartate, and glutamate 
metabolism, citrate cycle, and nitrogen metabolism)(Figure 6C).
To summarize the dynamic metabolic alterations throughout the entire experiment, a One-
Way ANOVA was performed on all the metabolites at each time point compared to the 6 
hours stretch (0 hr) time point (Figure 7, Figure 8, Supplemental Figure 3, Supplemental 
Figure 4). The metabolic process affected most prominently by ANOVA analysis is the 
Kreb’s Cycle (Figure 7). Since glucose uptake occurs in response to stretch, we followed 
media glucose levels as it was an identified metabolites found throughout. Glucose levels did 
not significantly change throughout the time course (Supplemental Figure 5). Significant 
increases in lactic acid, citric acid, α-ketoglutaric acid, and malate were identified and 
significantly increased by 12 hours of stretch cessation and hypertrophy reversal (see inset 
plots). Both ANOVA and t-tests identified decreases in pyruvate, complementing the 
analysis performed in Figure 6, investigating the significant alterations by t-test at the 12-
hour stretch cessation compared to the 6-hour hypertrophy time point (0 Hr), indicated in 
blue and red. In addition to the ANOVA significant findings, fumarate was found to be 
decreased 3.5 fold (Figure 7).
One-way ANOVA performed on all the time points revealed alterations in alanine and 
proline metabolism (Figure 8). As adjacent pathways to the Kreb’s cycle, increases in 
proline, alanine, glutamine, and asparagine were increased with the cessation of stretch by 
3–12 hours (Figure 8, see inset graphs). In addition to the ANOVA significant metabolites, 
the 12 hours t-test identified glutamate and glycine reduced (see metabolites in blue, Figure 
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8). Lastly, ANOVA significant metabolites were also identified in purine metabolism 
(Supplemental Figure 3A), branched chain amino acid synthesis (Supplemental Figure 3B), 
phospholipid metabolism (Supplemental Figure 3C), and in pathways not clearly delineated, 
including sugar alcohols identified as pentitols and hexitols (Supplemental Figure 4).
4.0 Discussion
Recent studies have demonstrated that cyclic stretch of differentiated C2C12 myotubes for 
as little as 1 hour per day (12% at 0.7 Hz) increases myocyte size in as little as two days8. To 
streamline this model, we found that in preliminary studies that stretching cells similarly 
(15% at 1.0 Hz) could induce myocyte growth in 6 hours, which became the basis for the 
present study. Cyclic stretch of C2C12 myotubes induces the release IGF-1 and AngII, 
which act as autocrine/paracrine stimulators of IGF-18 and Angiotensin II15 signaling on the 
C2C12 cells themselves, inducing an increase in cell size. As myocyte hypertrophy 
represents the increase in newly synthesized sarcomeres, the significance of the observed 
IGF-1 induced protein synthesis (evidenced by increased p-Akt and p-GSK3beta, 
respectively) is clear. Conversely, cessation of stretch reproducibly causes a loss of myocyte 
mass8, involving the proteasome-dependent degradation of sarcomere proteins that involves 
both the ubiquitin-proteasome system and calpain enzymes16,17. The myocyte-specific 
ubiquitin ligases MuRF1 and MAFbx mediate muscle atrophy18, recognizing and 
ubiquitinating sarcomere proteins, then targeted for proteasome-dependent degradation19. 
Atrophy in C2C12 myotubes can be inhibited by blocking the proteasome20 or by blocking 
ubiquitination to prevent atrophy in C2C12 myotubes16. Recent studies have identified that 
activating calpain enzymes serve to induce the ubiquitin-proteasome pathway, thereby acting 
in concerted to degrade sarcomere proteins during atrophy21.
The induction of anaplerosis in atrophy is an important compensatory mechanism by which 
amino acids feed the TCA cycle to generate energy. The link between atrophy and 
anaplerosis is logical, given the tremendous sarcomere protein degradation that occurs, 
freeing peptides and amino acids used for energy. In addition to the structural changes that 
occur with muscle unloading and atrophy, recent studies have identified an intricate link 
between skeletal muscle mass regulation and energy metabolism22. Conceptually, this link 
lies in the well-established increase in net protein degradation that produces an increase in 
amino acids5,7,23. During the development and progression of colorectal cancer, tumor-
bearing animals experienced decreases in pyruvate kinase (PKM1) and pyruvate kinase 
activity but were unexpectedly able to maintain energy7. These studies revealed that an 
increase in autophagy supported the loss of muscle mass and increased amino acid 
production, including increased glutamine7. Through a well-known process of anaplerosis 
that occurs in skeletal muscle, glutaminase can change glutamine to glutamate, whereby 
glutamate dehydrogenase can create the α-ketoglutaric acid intermediate to feed the TCA 
cycle24,25. During the progression of skeletal muscle atrophy due to cancer, increases in 
glutamine were thought to be the main mechanism by which ATP levels were maintained in 
the presence of decreased pyruvate kinase activity7. In the present study, we expand this 
evidence to demonstrate increases in alanine/proline metabolism (significantly elevated 
proline, alanine, glutamine, and asparagine, (Figure 8) and increased α-ketoglutaric acid, the 
proposed intermediate (Figure 7) being fed by the alanine/proline metabolic anaplerotic 
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mechanism. Lastly, the anaplerotic pathway shunting pyruvate to malate has been described 
as a potential anaplerotic mechanism in skeletal muscle through the malic enzyme26. While 
it has not clearly been described to our knowledge in unloading, it may be at work in the 
present model to describe the elevated malate seen after unloading (Figure 7).
In addition to the anaplerotic mechanism feeding α-ketoglutaric acid seen with C2C12 
unloading, we identified several unique pathways not clearly delineated in previous studies 
of muscle unloading. The CDP-ethanolamine pathway has been described to regulate 
skeletal muscle diacylglycerol content and mitochondrial biogenesis27. The drug clenbuterol 
is an ethanolamine that has been used to treat skeletal muscle atrophy, including 
dexamethasone-induced muscle atrophy28, denervated skeletal muscle29, and in treating 
humans with spinal and bulbar muscular atrophy for a 12 month trial30. These studies 
indicate that the ethanolamine clenbuterol protects skeletal muscle loss by antagonizing Akt/
mTOR and by increasing polyamines (putrescine, spermidine, and spermine), which are 
repressed in muscle atrophy31–33. The presence of elevated ethanolamine may represent 
novel endogenous pathways involved in the recovery of atrophy (Supplemental Figure 3C). 
Significantly increased concentration of the keto-acids derived from branched chain amino 
acids (i.e. 2-ketoleucine and 2-keovaline) were identified after unloading (Supplemental 
Figure 3B) and have been described as intermediates in the Ehrlich amino acid degradation 
pathway. These keto-acids derived from branched chain amino acids feed into a metabolic 
pathway supplying acetyl-CoA and 2-hydroxybutyrate (also significantly increased, Figure 
7). Since the keto-amino acids are further reacted in this pathway to make higher alcohols, it 
is possible that the generic sugar alcohols may be related to this process (Supplemental 
Figure 4A). While the elevation of amino acids during skeletal muscle atrophy is well 
known34, the keto-acids derived from branched chain amino acids seen here have not 
previously been described specifically. Lastly, elevated guanine was seen at 12 hours 
unloading, which previously was undetectable at multiple time points (Supplemental Figure 
3A). While guanine is an intermediate in purine metabolism, its role in unloading 
remodeling has not been described to our knowledge in the literature previously.
Metabolomic analysis of cell culture can involve extracellular (footprint) and intracellular 
(fingerprint) metabolic profiles. One advantage of metabolic footprinting is the ability to 
assay serially, as in the present study, to allow identification of changes over time in the 
same cell culture system. Footprinting of B-lymphocytes into Ig secreting plasma cells using 
supernatants identified the consumption of glucose, glutamine, and other essential amino 
acids35. 5′-methylthioadenosine (5′MTA) was produced and released during the activation 
phase, while the second phase of differentiation corresponded to deoxycytidine release35. 
Changes in extracellular metabolites correlated with the known biochemical pathway 
changes reported previously35. The secretome footprinting of cancer cells has similarly 
shown parallels between the metabolites secreted and the underlying biology of the cells 
releasing these metaoblites36. Specifically, identification of isoleucine, α-aminoadipic acid 
(AADA), and γ-amino-N-butyric acid (GABA) in media were accurate biomarkers of c-
Myc, KLF4, and Oct1 variable expression, with modulation of these markers indicative of 
changes in the underlying biology of the tumor36. The reason for the parallel metabolic 
mirroring of the footprint with the intracellular (fingerprint) in these studies is not addressed 
directly in these studies.
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One potential mechanism that may explain the parallel metabolomics profiles seen in 
extracellular media and cells alike may be exosome-like vesicles (ELV)37. Small molecule 
profiling from ELVs isolated from cell culture media has recently demonstrated to be much 
more dynamic. The rich metabolome that was found included glycerophospholipids/
sphingolipids, peptides, cyclic alcohols, fatty acid esters/amides, alcohols, sugars, steroids, 
amino acids/conjugates, nucleotides, and organic acids in cell culture media from exosome-
like vesicles found in the media37. While we did not isolate ELVs from media in the present 
study, this finding demonstrates that the diversity of metabolites we did identify have been 
reported in media ELVs as a source. The transport and movement of these diverse 
metabolites are not well described but are different enough that multiple mechanisms, 
including those outside of ELVs not previously described, may similarly be involved.
A limitation of this study is the limited fatty acids available to the differentiated C2C12 cells 
during the stretch phase and subsequent hypertrophy reversal. C2C12 cells have the ability 
to take up and oxidize fatty acids for energy production and have the ability to store fats as 
triglycerides as well38. Adequate supplementation of fatty acids complexed to albumin was 
available in the serum used to proliferate and differentiate these cells. DMEM with 10% 
fetal bovine serum was used to induce proliferation of C2C12 myoblasts; the media was then 
replaced with DMEM with 2% horse serum to induce differentiation. However, the stretch 
studies were then performed in the absence of serum as serum is a potent inducer of 
hypertrophic growth (containing IGF-1, Angiotensin II, and thyroid hormone, among other 
pro-hypertrophic constituents8,15; see serum-induced hypertrophic controls, Supplemental 
Figure 1). While fatty acids were not directly added to the media via serum for these 
reasons, fatty acids were identified in the media by our present analysis. Specifically, 
palmitic acid, alpha-Monopalmitin, and/or Beta-Monopalmitin were found at each time 
found (Supplemental Table 1). Recent studies have demonstrated that the essential fatty 
acids linoleic acid (LA) and alpha-linolenic acid (ALA) themselves can improve glucose 
uptake in C2C12 cells made insulin resistant using palmitic acid39, making the balance 
between fatty acids and glucose critically important when modeling myocytes in vitro.
5.0 Conclusions
Cessation of biaxial stretch in C2C12 myotubes in culture resulted in a reduction in cross-
sectional area over 12 hours, paralleling some metabolic changes using non-targeted 
metabolomics analysis of the media. Using a One-Way ANOVA analysis comparing the 
cessation time point, increases in amino acids were identified, resulting from the protein 
degradation (largely sarcomere) that occurs with muscle atrophy. Increases in alanine/proline 
metabolism (significantly elevated proline, alanine, glutamine, and asparagine) and 
increased α-ketoglutaric acid, the proposed intermediate being fed by the alanine/proline 
metabolic anaplerotic mechanism were identified. Additionally, several unique pathways not 
clearly delineated in previous studies of muscle unloading were seen, including: 1) elevated 
keto-acids derived from branched chain amino acids (i.e. 2-ketoleucine and 2-keovaline), 
which feed into a metabolic pathway supplying acetyl-CoA and 2-hydroxybutyrate (also 
significantly increased); and 2) elevated guanine, an intermediate of purine metabolism, was 
seen at 12 hours unloading. Given the interest in targeting different aspects of the ubiquitin-
proteasome system to inhibit protein degradation18,40,41, this C2C12 system may allow the 
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identification of direct and indirect alterations in metabolism due to anaplerosis or through 
other yet to be identified mechanisms using a non-targeted metabolomics approach.
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Acknowledgments
This work was supported by the National Institutes of Health (R01HL104129 to M.W.), the Jefferson-Pilot 
Corporation (Fellowship to M.W.), and the Leducq Foundation Transatlantic Networks of Excellence (to M.W.).
Non-standard abbreviations
PKM1 pyruvate kinase
TCA cycle tri-carboxylic acid cycle
References
1. Deitrick JE. The effect of immobilization on metabolic and physiological functions of normal men. 
Bull N Y Acad Med. 1948; 24(6):364–375. [PubMed: 18860463] 
2. Gibson JN, Halliday D, Morrison WL, et al. Decrease in human quadriceps muscle protein turnover 
consequent upon leg immobilization. Clin Sci (Lond). 1987; 72(4):503–509. [PubMed: 2435445] 
3. Ingemann-Hansen T, Halkjaer-Kristensen J. Computerized tomographic determination of human 
thigh components. The effects of immobilization in plaster and subsequent physical training. Scand 
J Rehabil Med. 1980; 12(1):27–31. [PubMed: 7384763] 
4. Christensen T, Bendix T, Kehlet H. Fatigue and cardiorespiratory function following abdominal 
surgery. Br J Surg. 1982; 69(7):417–419. [PubMed: 7104617] 
5. Wall BT, Dirks ML, van Loon LJ. Skeletal muscle atrophy during short-term disuse: implications for 
age-related sarcopenia. Ageing Res Rev. 2013; 12(4):898–906. [PubMed: 23948422] 
6. Stein TP, Wade CE. Metabolic consequences of muscle disuse atrophy. J Nutr. 2005; 135(7):1824S–
1828S. [PubMed: 15987873] 
7. Luo Y, Yoneda J, Ohmori H, et al. Cancer usurps skeletal muscle as an energy repository. Cancer 
Res. 2014; 74(1):330–340. [PubMed: 24197136] 
8. Soltow QA, Zeanah EH, Lira VA, Criswell DS. Cessation of cyclic stretch induces atrophy of 
C2C12 myotubes. Biochem Biophys Res Commun. 2013; 434(2):316–321. [PubMed: 23541574] 
9. Yaffe D, Saxel O. Serial passaging and differentiation of myogenic cells isolated from dystrophic 
mouse muscle. Nature. 1977; 270(5639):725–727. [PubMed: 563524] 
10. Casas-Delucchi CS, Brero A, Rahn HP, et al. Histone acetylation controls the inactive X 
chromosome replication dynamics. Nat Commun. 2011; 2:222. [PubMed: 21364561] 
11. Blau HM, Pavlath GK, Hardeman EC, et al. Plasticity of the differentiated state. Science. 1985; 
230(4727):758–766. [PubMed: 2414846] 
12. Wadosky KM, Rodriguez JE, Hite RL, Min JN, Walton BL, Willis MS. Muscle RING finger-1 
attenuates IGF-I-dependent cardiomyocyte hypertrophy by inhibiting JNK signaling. Am J Physiol 
Endocrinol Metab. 2014; 306(7):E723–739. [PubMed: 24425758] 
13. Wadosky KM, Berthiaume J, Tang W, et al. MuRF1 mono-ubiquitinates TRalpha to inhibit T3 
induced cardiac hypertrophy in vivo. J Mol Endocrinol. 2016
14. Banerjee R, Bultman SJ, Holley D, et al. Non-targeted metabolomics of double-mutant 
cardiomyocytes reveals a novel role for SWI/SNF complexes in metabolic homeostasis. 
Metabolomics. 2015; 11(5):1287–1301. [PubMed: 26392817] 
Ilaiwy et al. Page 9
Int J Biochem Cell Biol. Author manuscript; available in PMC 2017 October 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
15. Johnston AP, Baker J, De Lisio M, Parise G. Skeletal muscle myoblasts possess a stretch-
responsive local angiotensin signalling system. J Renin Angiotensin Aldosterone Syst. 2011; 
12(2):75–84. [PubMed: 20921089] 
16. Kawai N, Hirasaka K, Maeda T, et al. Prevention of skeletal muscle atrophy in vitro using anti-
ubiquitination oligopeptide carried by atelocollagen. Biochim Biophys Acta. 2015; 1853(5):873–
880. [PubMed: 25667084] 
17. Salazar JJ, Michele DE, Brooks SV. Inhibition of calpain prevents muscle weakness and disruption 
of sarcomere structure during hindlimb suspension. J Appl Physiol (1985). 2010; 108(1):120–127. 
[PubMed: 19892928] 
18. Bodine SC, Latres E, Baumhueter S, et al. Identification of ubiquitin ligases required for skeletal 
muscle atrophy. Science. 2001; 294(5547):1704–1708. [PubMed: 11679633] 
19. Willis MS, Patterson C. Into the heart: the emerging role of the ubiquitin-proteasome system. J Mol 
Cell Cardiol. 2006; 41(4):567–579. [PubMed: 16949602] 
20. Polge C, Heng AE, Jarzaguet M, et al. Muscle actin is polyubiquitinylated in vitro and in vivo and 
targeted for breakdown by the E3 ligase MuRF1. FASEB J. 2011; 25(11):3790–3802. [PubMed: 
21764995] 
21. Kramerova I, Kudryashova E, Venkatraman G, Spencer MJ. Calpain 3 participates in sarcomere 
remodeling by acting upstream of the ubiquitin-proteasome pathway. Hum Mol Genet. 2005; 
14(15):2125–2134. [PubMed: 15961411] 
22. Koopman R, Ly CH, Ryall JG. A metabolic link to skeletal muscle wasting and regeneration. Front 
Physiol. 2014; 5:32. [PubMed: 24567722] 
23. Kachaeva EV, Shenkman BS. Various jobs of proteolytic enzymes in skeletal muscle during 
unloading: facts and speculations. J Biomed Biotechnol. 2012; 2012:493618. [PubMed: 22496611] 
24. Gibala MJ, Young ME, Taegtmeyer H. Anaplerosis of the citric acid cycle: role in energy 
metabolism of heart and skeletal muscle. Acta Physiol Scand. 2000; 168(4):657–665. [PubMed: 
10759602] 
25. Gupte AA, Hamilton DJ, Cordero-Reyes AM, et al. Mechanical unloading promotes myocardial 
energy recovery in human heart failure. Circ Cardiovasc Genet. 2014; 7(3):266–276. [PubMed: 
24825877] 
26. Gibala MJ. Regulation of skeletal muscle amino acid metabolism during exercise. Int J Sport Nutr 
Exerc Metab. 2001; 11(1):87–108. [PubMed: 11255139] 
27. Selathurai A, Kowalski GM, Burch ML, et al. The CDP-Ethanolamine Pathway Regulates Skeletal 
Muscle Diacylglycerol Content and Mitochondrial Biogenesis without Altering Insulin Sensitivity. 
Cell Metab. 2015; 21(5):718–730. [PubMed: 25955207] 
28. Umeki D, Ohnuki Y, Mototani Y, et al. Protective Effects of Clenbuterol against Dexamethasone-
Induced Masseter Muscle Atrophy and Myosin Heavy Chain Transition. PLoS One. 2015; 
10(6):e0128263. [PubMed: 26053620] 
29. Goncalves DA, Silveira WA, Lira EC, et al. Clenbuterol suppresses proteasomal and lysosomal 
proteolysis and atrophy-related genes in denervated rat soleus muscles independently of Akt. Am J 
Physiol Endocrinol Metab. 2012; 302(1):E123–133. [PubMed: 21952035] 
30. Querin G, D’Ascenzo C, Peterle E, et al. Pilot trial of clenbuterol in spinal and bulbar muscular 
atrophy. Neurology. 2013; 80(23):2095–2098. [PubMed: 23645595] 
31. Bongers KS, Fox DK, Kunkel SD, et al. Spermine oxidase maintains basal skeletal muscle gene 
expression and fiber size and is strongly repressed by conditions that cause skeletal muscle 
atrophy. Am J Physiol Endocrinol Metab. 2015; 308(2):E144–158. [PubMed: 25406264] 
32. Szathmary I, Selmeci L, Szobor A, Molnar J. Altered polyamine levels in skeletal muscle of 
patients with myasthenia gravis. Clin Neuropathol. 1994; 13(4):181–184. [PubMed: 7955662] 
33. Abukhalaf IK, von Deutsch DA, Wineski LE, et al. Effect of hindlimb suspension and clenbuterol 
treatment on polyamine levels in skeletal muscle. Pharmacology. 2002; 65(3):145–154. [PubMed: 
12037378] 
34. Schakman O, Kalista S, Barbe C, Loumaye A, Thissen JP. Glucocorticoid-induced skeletal muscle 
atrophy. Int J Biochem Cell Biol. 2013; 45(10):2163–2172. [PubMed: 23806868] 
35. Garcia-Manteiga JM, Mari S, Godejohann M, et al. Metabolomics of B to plasma cell 
differentiation. J Proteome Res. 2011; 10(9):4165–4176. [PubMed: 21744784] 
Ilaiwy et al. Page 10
Int J Biochem Cell Biol. Author manuscript; available in PMC 2017 October 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
36. Bellance N, Pabst L, Allen G, Rossignol R, Nagrath D. Oncosecretomics coupled to bioenergetics 
identifies alpha-amino adipic acid, isoleucine and GABA as potential biomarkers of cancer: 
Differential expression of c-Myc, Oct1 and KLF4 coordinates metabolic changes. Biochim 
Biophys Acta. 2012; 1817(11):2060–2071. [PubMed: 22842522] 
37. Altadill T, Campoy I, Lanau L, et al. Enabling Metabolomics Based Biomarker Discovery Studies 
Using Molecular Phenotyping of Exosome-Like Vesicles. PLoS One. 2016; 11(3):e0151339. 
[PubMed: 26974972] 
38. Bastie CC, Hajri T, Drover VA, Grimaldi PA, Abumrad NA. CD36 in myocytes channels fatty 
acids to a lipase-accessible triglyceride pool that is related to cell lipid and insulin responsiveness. 
Diabetes. 2004; 53(9):2209–2216. [PubMed: 15331529] 
39. Park SY, Kim MH, Ahn JH, et al. The Stimulatory Effect of Essential Fatty Acids on Glucose 
Uptake Involves Both Akt and AMPK Activation in C2C12 Skeletal Muscle Cells. Korean J 
Physiol Pharmacol. 2014; 18(3):255–261. [PubMed: 24976766] 
40. Jagoe RT, Goldberg AL. What do we really know about the ubiquitin-proteasome pathway in 
muscle atrophy? Curr Opin Clin Nutr Metab Care. 2001; 4(3):183–190. [PubMed: 11517350] 
41. Smith IJ, Lecker SH, Hasselgren PO. Calpain activity and muscle wasting in sepsis. Am J Physiol 
Endocrinol Metab. 2008; 295(4):E762–771. [PubMed: 18492780] 
42. Bertolo RF, Burrin DG. Comparative aspects of tissue glutamine and proline metabolism. J Nutr. 
2008; 138(10):2032S–2039S. [PubMed: 18806120] 
Ilaiwy et al. Page 11
Int J Biochem Cell Biol. Author manuscript; available in PMC 2017 October 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 1. Stretch-induced C2C12 hypertrophy and reversal model
A. Experimental design using differentiated C2C12 in the absence of serum. B. 
Photomicrographs of control time-matched sham and stretch/reversal cells (N=3/group). C. 
Quantification of cross-section area of differentiated C2C12 cells normalized to sham / no 
stretch controls (N=80-100 cells/group, indicated in bars as stretch cell # / control cell # 
included in cross-sectional area counts). A One-Way ANOVA followed by Holm-Sidak 
pairwise post-hoc all pairwise analysis was performed to compare cell size over time.
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Figure 2. Non-targeted metabolomics of C2C12 myotube media with no serum, after 6 hours of 
stretch, compared to serum free media of non-stretched C2C12 myotubes after 0-1-3-6 hours of 
no stretch (one replicate each)
A. Heat map of metabolites identified by non-targeted GC/MS analysis. B. T-test significant 
metabolites with fold change and p-values. C. Pathway analysis of T-test significant 
metabolites, N=3 (6 hours stretch), N=4 (no stretch controls).
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Figure 3. Non-targeted metabolomics of media from C2C12 stretched myotubes with no serum, 
after 1 hour of unloading (post 6 hours stretch) compared to media from C2C12 myotubes after 
6 hours of stretch
A. Heat map of metabolites identified by non-targeted GC/MS analysis. B. T-test significant 
metabolites with fold change and p-values. C. Pathway analysis of T-test significant 
metabolites, N=3/group.
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Figure 4. Non-targeted metabolomics of media from C2C12 stretched myotubes with no serum, 
after 3 hours of unloading (post 6 hours stretch) compared to media from C2C12 myotubes after 
6 hours of stretch
A. Heat map of metabolites identified by non-targeted GC/MS analysis. B. T-test significant 
metabolites with fold change and p-values. C. Pathway analysis of T-test significant 
metabolites, N=3/group.
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Figure 5. Non-targeted metabolomics of media from C2C12 stretched myotubes with no serum, 
after 6 hours of unloading (post 6 hours stretch) compared to media from C2C12 myotubes after 
6 hours of stretch
A. Heat map of metabolites identified by non-targeted GC/MS analysis. B. T-test significant 
metabolites with fold change and p-values. C. Pathway analysis of T-test significant 
metabolites, N=3/group.
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Figure 6. Non-targeted metabolomics of media from C2C12 stretched myotubes with no serum, 
after 12 hours of unloading (post 6 hours stretch) compared to media from C2C12 myotubes 
after 6 hours of stretch
A. Heat map of metabolites identified by non-targeted GC/MS analysis. B. T-test significant 
metabolites with fold change and p-values. C. Pathway analysis of T-test significant 
metabolites, N=3/group.
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Figure 7. T-test and ANOVA significant changes in the Kreb’s Cycle intermediates from C2C12 
stretched myotube media after 12 hours of unloading (post 6 hours stretch) compared to no 
stretch time-matched controls
T-test significant alterations indicated in either red (decreased) or blue (increased) with 
ANOVA significant alterations indicated by inset graph of changes over time.
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Figure 8. T-test and ANOVA significant changes in glutamine and citrulline metabolism in 
C2C12 stretched myotube media after 12 hours of unloading (post 6 hours stretch) compared to 
no stretch time-matched controls
T-test significant alterations indicated in either red (decreased) or blue (increased) with 
ANOVA significant alterations indicated by inset graph of changes over time. Glutamine/
proline metabolism pathways adapted from Bertolo and Burrin, 200842. *p<0.05 vs. 6-hour 
stretch time point.
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